EP3151822A4 - Fixed dose combination for pain relief without edema - Google Patents
Fixed dose combination for pain relief without edema Download PDFInfo
- Publication number
- EP3151822A4 EP3151822A4 EP15806490.7A EP15806490A EP3151822A4 EP 3151822 A4 EP3151822 A4 EP 3151822A4 EP 15806490 A EP15806490 A EP 15806490A EP 3151822 A4 EP3151822 A4 EP 3151822A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- edema
- pain relief
- fixed dose
- dose combination
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462009300P | 2014-06-08 | 2014-06-08 | |
US201462023962P | 2014-07-14 | 2014-07-14 | |
PCT/US2015/011148 WO2016114761A1 (en) | 2015-01-13 | 2015-01-13 | Method for individualized drug therapy |
PCT/US2015/034706 WO2015191460A1 (en) | 2014-06-08 | 2015-06-08 | Fixed dose combination for pain relief without edema |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3151822A1 EP3151822A1 (en) | 2017-04-12 |
EP3151822A4 true EP3151822A4 (en) | 2017-11-22 |
Family
ID=54834151
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15806490.7A Withdrawn EP3151822A4 (en) | 2014-06-08 | 2015-06-08 | Fixed dose combination for pain relief without edema |
EP15807276.9A Withdrawn EP3151823A4 (en) | 2014-06-08 | 2015-06-08 | Fixed dose combination for pain relief without edema |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15807276.9A Withdrawn EP3151823A4 (en) | 2014-06-08 | 2015-06-08 | Fixed dose combination for pain relief without edema |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP3151822A4 (en) |
JP (2) | JP2017517529A (en) |
KR (2) | KR20160091349A (en) |
CN (2) | CN106572985A (en) |
AU (2) | AU2015274895A1 (en) |
CA (2) | CA2956899A1 (en) |
TW (2) | TW201642854A (en) |
WO (2) | WO2015191473A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016115057A1 (en) * | 2015-01-13 | 2016-07-21 | Autotelic Llc | Fixed dose combination for pain relief without edema |
EP3384282A1 (en) * | 2015-11-30 | 2018-10-10 | Pharnext | Method for adapting doses of combination therapies |
KR20220113436A (en) * | 2019-12-04 | 2022-08-12 | 레스큐 파마슈티컬스 엘엘씨 | Methods and compositions for treating edema refractory to oral diuretics |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006058073A2 (en) * | 2004-11-23 | 2006-06-01 | Transform Pharmaceuticals, Inc. | Pharmaceutical compositions comprising a selective cox-2 inhibitor and a diuretic |
WO2009154944A2 (en) * | 2008-05-28 | 2009-12-23 | Hoyle Peter C | Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1299122A2 (en) * | 2000-07-13 | 2003-04-09 | Pharmacia Corporation | Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain |
EP1990049A3 (en) * | 2005-03-21 | 2008-11-26 | Vicus Therapeutics SPE 1, LLC | Combination therapy of beta-blockers and non-steroidal anti-inflammatory drugs (NSAID) |
EP2014284A1 (en) * | 2007-06-15 | 2009-01-14 | Novartis AG | Pharmaceutical compositions and uses |
EP2715359A4 (en) * | 2011-05-30 | 2015-01-21 | String Therapeutics Inc | Methods and compositions for therapeutic drug monitoring and dosing by point-of-care pharmacokinetic profiling |
-
2015
- 2015-06-08 CN CN201580042156.9A patent/CN106572985A/en active Pending
- 2015-06-08 CA CA2956899A patent/CA2956899A1/en not_active Abandoned
- 2015-06-08 JP JP2016571720A patent/JP2017517529A/en active Pending
- 2015-06-08 JP JP2017516649A patent/JP2017517575A/en active Pending
- 2015-06-08 CA CA2956897A patent/CA2956897A1/en not_active Abandoned
- 2015-06-08 EP EP15806490.7A patent/EP3151822A4/en not_active Withdrawn
- 2015-06-08 KR KR1020167015176A patent/KR20160091349A/en not_active Application Discontinuation
- 2015-06-08 AU AU2015274895A patent/AU2015274895A1/en not_active Abandoned
- 2015-06-08 AU AU2015274908A patent/AU2015274908A1/en not_active Abandoned
- 2015-06-08 EP EP15807276.9A patent/EP3151823A4/en not_active Withdrawn
- 2015-06-08 CN CN201580040734.5A patent/CN106572984A/en active Pending
- 2015-06-08 WO PCT/US2015/034738 patent/WO2015191473A1/en active Application Filing
- 2015-06-08 KR KR1020167015173A patent/KR20160091348A/en not_active Application Discontinuation
- 2015-06-08 WO PCT/US2015/034706 patent/WO2015191460A1/en active Application Filing
-
2016
- 2016-03-28 TW TW105109706A patent/TW201642854A/en unknown
- 2016-03-28 TW TW105109708A patent/TW201642906A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006058073A2 (en) * | 2004-11-23 | 2006-06-01 | Transform Pharmaceuticals, Inc. | Pharmaceutical compositions comprising a selective cox-2 inhibitor and a diuretic |
WO2009154944A2 (en) * | 2008-05-28 | 2009-12-23 | Hoyle Peter C | Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds |
Non-Patent Citations (4)
Title |
---|
MOORE R ANDREW ET AL: "Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports", ARTHRITIS RESEARCH, CURRENT SCIENCE, LONDON, GB, vol. 7, no. 3, 24 March 2005 (2005-03-24), pages R644 - R665, XP021011594, ISSN: 1465-9905, DOI: 10.1186/AR1704 * |
SANJIVE QAZI ET AL: "Abstract 2597: Celecoxib fixed dose combinations - patient level data analyses", CANCER RESEARCH, vol. 77, no. 13 Supplement, 1 July 2017 (2017-07-01), US, pages 2597 - 2597, XP055416583, ISSN: 0008-5472, DOI: 10.1158/1538-7445.AM2017-2597 * |
See also references of WO2015191460A1 * |
W WANG ET AL: "Poster Number 110: Patient-level Data Analysis Revealed the Real Incidence and Impact of Celecoxib on Edema", CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, vol. 6, no. Suppl 1, 1 September 2017 (2017-09-01), pages 69 - 70, XP055416585, DOI: 10.1002/cpdd.385 * |
Also Published As
Publication number | Publication date |
---|---|
CA2956899A1 (en) | 2015-12-17 |
TW201642906A (en) | 2016-12-16 |
CN106572984A (en) | 2017-04-19 |
AU2015274908A1 (en) | 2017-01-19 |
WO2015191473A1 (en) | 2015-12-17 |
JP2017517575A (en) | 2017-06-29 |
CA2956897A1 (en) | 2015-12-17 |
JP2017517529A (en) | 2017-06-29 |
TW201642854A (en) | 2016-12-16 |
WO2015191473A9 (en) | 2016-03-24 |
KR20160091348A (en) | 2016-08-02 |
EP3151822A1 (en) | 2017-04-12 |
AU2015274895A1 (en) | 2017-02-02 |
WO2015191460A1 (en) | 2015-12-17 |
KR20160091349A (en) | 2016-08-02 |
CN106572985A (en) | 2017-04-19 |
EP3151823A1 (en) | 2017-04-12 |
EP3151823A4 (en) | 2017-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3463464A4 (en) | Combination therapy | |
EP3332717A4 (en) | Treatment device | |
EP3199628A4 (en) | Cytotoxicity-inducing therapeutic agent | |
EP3104807B8 (en) | Device for teeth treatment | |
EP3180010A4 (en) | Combination therapy for treating cancer | |
EP3169325A4 (en) | Therapeutic inhibitory compounds | |
EP3445750A4 (en) | Therapeutic compounds | |
EP3184093A4 (en) | Massage device | |
EP3193884A4 (en) | Combination therapy for treating cancer | |
EP3229974A4 (en) | Antiseptic applicator | |
EP3020430A4 (en) | Cannula for catgut-embedding therapy | |
GB201415569D0 (en) | Therapeutic Compounds | |
EP3515414A4 (en) | Combination therapy | |
EP3188721A4 (en) | Human therapeutic agents | |
EP3362091A4 (en) | Combination treatment | |
EP3097880A4 (en) | Therapeutic apparatus | |
EP3512553A4 (en) | Klrg1 depletion therapy | |
EP3157631A4 (en) | Neurodegenerative disease treatment | |
EP3419959A4 (en) | Combination therapy | |
EP3271014A4 (en) | Phototherapy device | |
EP3259254A4 (en) | Therapeutic compounds | |
EP3171876A4 (en) | Combination therapy | |
EP3131619A4 (en) | Stimulating devices | |
EP3302394A4 (en) | Devices for sexual stimulation | |
EP3215102A4 (en) | Medicament dispenser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20170109 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20171025 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/549 20060101ALI20171019BHEP Ipc: A61K 45/06 20060101ALI20171019BHEP Ipc: A61P 7/10 20060101ALI20171019BHEP Ipc: A61K 9/00 20060101AFI20171019BHEP Ipc: A61K 31/635 20060101ALI20171019BHEP Ipc: A61P 25/00 20060101ALI20171019BHEP Ipc: A61P 29/00 20060101ALI20171019BHEP Ipc: A61K 31/415 20060101ALI20171019BHEP Ipc: A61P 43/00 20060101ALI20171019BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20180523 |